Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Executive Vice President | February 01, 2018 | February 14, 2018 |
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director · Chief Executive Officer | May 15, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date February 01, 2018 · Filed February 14, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,437 |
Reported balance
After 2018-02-01 transaction · row 1
1 source rowRow 1 · 2018-02-01 · Exercise / conversion · Acquired 180 · Balance 13,437 F1: The securities convert to common stock on a one-for-one basis. |
| Rights to Common Stock Under the Deferred Compensation PlanSEC Table II · derivative / convertible security | Direct | 782 |
Reported balance
After 2018-02-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-02-01 · Exercise / conversion · Disposed 180 · Balance 782 F1: The securities convert to common stock on a one-for-one basis. F4: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person. |
| Common StockSEC Table I · non-derivative | IndirectGSIP Trust | 1,552 |
Reported balance
Holding disclosure · report date 2018-02-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,552 F2: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of January 31, 2018. |
| Common StockSEC Table I · non-derivative | IndirectSIP Trust | 99 |
Reported balance
Holding disclosure · report date 2018-02-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 99 F3: Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of November 30, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities convert to common stock on a one-for-one basis.
F2: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of January 31, 2018.
F3: Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of November 30, 2017.
F4: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person.
KORU Medical Systems, Inc.
Report date May 15, 2026 · Filed May 20, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 620,622 |
Reported balance
After 2026-05-15 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-15 · Purchase · Acquired 1,191 · Balance 620,622 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 20, 2026 20:27 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 1,191 | $3.92 | $4,668.72 |
DisclosureSEC source: 0001161697-26-000124 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,622 Read SEC document |
| May 15, 2026 Filed May 20, 2026 20:02 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 1,191 | $1,191.00 | $1,418,481.00 |
DisclosureSEC source: 0001161697-26-000122 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 620,622 Read SEC document |
| May 14, 2026 Filed May 19, 2026 21:08 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 7,326 | $3.94 | $28,864.44 |
DisclosureSEC source: 0001161697-26-000120 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 619,431 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| May 14, 2026 Filed May 19, 2026 21:08 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionCommon Stock | 13,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000120 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 626,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:42 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 5,756 | $4.28 | $24,635.68 |
DisclosureSEC source: 0001161697-26-000058 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,212 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:42 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionCommon Stock | 15,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-26-000058 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| October 16, 2025 Filed Oct 20, 2025 20:09 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 29,463 | $4.08 | $120,209.04 |
DisclosureSEC source: 0001161697-25-000367 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,626 F1 · shares: 29,463 shares issued per her employment agreement for 2024 annual bonus earned, of which 70% was paid in cash and 30% paid in shares of common stock. F2 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantOption to buy Common Stock · Derivative | 94,772 | $0.00 Strike: $3.21 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,772 Underlying: Common Stock · 94,772 shares Expires 2035-05-12 F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F5 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantRestricted Stock Units · Derivative | 111,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,729 Underlying: Common Stock · 111,729 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F4 · derivative.exercise_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. F4 · derivative.expiration_date: These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027. Read SEC document |
| May 12, 2025 Filed Aug 11, 2025 20:26 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantRestricted Stock Units · Derivative | 55,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000250 · form_4.xml · derivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,911 Underlying: Common Stock · 55,911 shares Expires not disclosed F1 · security: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F1 · kind: Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program. F3 · derivative.exercise_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F3 · derivative.expiration_date: One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 20:12 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 23,587 | $2.20 | $51,891.40 |
DisclosureSEC source: 0001161697-25-000148 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,023,163 F1 · kind: Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock. F2 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 29,813 | $2.83 | $84,370.79 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,750 F3 · kind: Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionRestricted Stock Unit · Derivative | 15,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · derivative · entry 4 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,904 Underlying: Common Stock · 15,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · price: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · derivative.exercise_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · derivative.expiration_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 8,848 | $2.89 | $25,546.83 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,563 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Exercise / conversionCommon Stock | 15,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,085,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantOption to buy Common Stock · Derivative | 140,950 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,950 Underlying: Common Stock · 140,950 shares Expires 2034-08-15 F4 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantRestricted Stock Units · Derivative | 127,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,660 Underlying: Common Stock · 127,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. F3 · derivative.expiration_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantRestricted Stock Units · Derivative | 63,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,872 Underlying: Common Stock · 63,872 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:21 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 7,094 | $2.09 | $14,826.46 |
DisclosureSEC source: 0001161697-24-000150 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,069,443 F3 · shares: Represents shares of common stock withheld by the issuer in satisfaction of tax withholding obligations upon the issuance of common stock for the portion of the 2023 bonus paid out in equity F2 · balance_after: Includes 200,000 in restricted stock awards that vest in 25% increments annually on 4/12/22,4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:21 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 19,681 | $2.09 | $41,133.29 |
DisclosureSEC source: 0001161697-24-000150 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,537 F1 · shares: Shares earned per her employment agreement for bonus of which 70% was paid in cash and 30% paid in shares of the Company's common stock. F2 · balance_after: Includes 200,000 in restricted stock awards that vest in 25% increments annually on 4/12/22,4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| August 18, 2023 Filed Aug 24, 2023 13:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 5,272 | $2.53 | $13,336.05 |
DisclosureSEC source: 0001161697-23-000465 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,056,676 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:36 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 11,278 | $3.71 | $41,841.38 |
DisclosureSEC source: 0001161697-23-000160 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,404 F3 · shares: Represents shares of common stock withheld by the issuer in satisfaction of tax withholding obligations upon the issuance of common stock for the portion of the 2022 bonus paid out in equity. F2 · balance_after: Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; Includes 400,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:36 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 32,378 | $3.71 | $120,122.38 |
DisclosureSEC source: 0001161697-23-000160 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,062,682 F1 · shares: 32,378 shares issued per her employment agreement for bonus earned of which 70% was paid in cash and 30% paid in shares of the company stock. F2 · balance_after: Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; Includes 400,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; Includes 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| May 13, 2022 Filed May 16, 2022 20:11 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 9,897 | $2.20 | $21,725.89 |
DisclosureSEC source: 0001161697-22-000243 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030,304 Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:11 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | PurchaseCommon Stock | 300 | $2.00 | $600.00 |
DisclosureSEC source: 0001161697-22-000243 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,407 Read SEC document |
| March 04, 2022 Filed Apr 13, 2022 15:48 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | Tax withholdingCommon Stock | 11,334 | $3.03 | $34,342.02 |
DisclosureSEC source: 0001161697-22-000181 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,020,107 F3 · shares: Represents shares of common stock withheld by the issuer in satisfaction of tax withholding obligations upon the issuance of common stock for the portion of the 2021 bonus paid in equity. F2 · balance_after: Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 04, 2022 Filed Apr 13, 2022 15:48 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 31,441 | $3.03 | $95,266.23 |
DisclosureSEC source: 0001161697-22-000181 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,031,441 F1 · shares: Represents shares of common stock issued as a portion of the 2021 bonus paid in equity. F2 · balance_after: Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:57 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-21-000210 · form_4.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F3 · shares: Restricted stock awards vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:57 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-21-000210 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F2 · shares: Restricted stock awards vest based on a schedule of the Company's market capitalization prior to 3/15/27. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:57 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-21-000210 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F1 · shares: Restricted stock awards vest in 25% increments annually beginning 3/15/22. Read SEC document |
| February 01, 2018 Filed Feb 14, 2018 19:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionRights to Common Stock Under the Deferred Compensation Plan · Derivative | 180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001543407-18-000028 · edgar.xml · derivative · entry 4 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 782 Underlying: Common Stock · 782 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F1 · price: The securities convert to common stock on a one-for-one basis. F4 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person. F4 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person. Read SEC document |
| February 01, 2018 Filed Feb 14, 2018 19:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001543407-18-000028 · edgar.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The securities convert to common stock on a one-for-one basis. Read SEC document |
| November 26, 2017 Filed Nov 28, 2017 14:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 14,280 | $0.00 Strike: $226.28 | $0.00 |
DisclosureSEC source: 0001543407-17-000047 · edgar.xml · derivative · entry 6 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,280 Underlying: Common Stock · 14,280 shares Expires 2027-11-26 F6 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2018. Read SEC document |
| November 25, 2017 Filed Nov 28, 2017 14:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 3,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000047 · edgar.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,767 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 25, 2017 Filed Nov 28, 2017 14:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000047 · edgar.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,943 F1 · shares: Represents shares vesting under performance units granted on November 25, 2014. Read SEC document |
| November 03, 2017 Filed Nov 8, 2017 18:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | OtherRights to Common Stock Under the Deferred Compensation Plan · Derivative | 962 | $224.41 | $215,882.42 |
DisclosureSEC source: 0001543407-17-000040 · edgar.xml · derivative · entry 1 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962 Underlying: Common Stock · 962 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service, or on the date or dates specified by the reporting person. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 21:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 7,333 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001543407-17-000032 · edgar.xml · derivative · entry 6 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,333 Underlying: Common Stock · 7,333 shares Expires 2021-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 22, 2012. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 21:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 4,695 | $200.48 | $941,253.60 |
DisclosureSEC source: 0001543407-17-000032 · edgar.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,337 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $200.40 through $200.65. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 21:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 2,638 | $200.48 | $528,866.24 |
DisclosureSEC source: 0001543407-17-000032 · edgar.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,032 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $200.40 through $200.65. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 21:45 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 7,333 | $72.12 | $528,855.96 |
DisclosureSEC source: 0001543407-17-000032 · edgar.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2016 Filed Nov 29, 2016 15:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 16,034 | $0.00 Strike: $170.69 | $0.00 |
DisclosureSEC source: 0001543407-16-000138 · edgar.xml · derivative · entry 6 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,034 Underlying: Common Stock · 16,034 shares Expires 2026-11-26 F6 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2017. Read SEC document |
| November 26, 2016 Filed Nov 29, 2016 15:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-16-000138 · edgar.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,337 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2016 Filed Nov 29, 2016 15:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 2,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-16-000138 · edgar.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,702 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of the performance units referred to in footnote (1) and the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2016 Filed Nov 29, 2016 15:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-16-000138 · edgar.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,896 F1 · shares: Represents shares vesting under performance units granted on November 26, 2013. Read SEC document |
| November 26, 2016 Filed Nov 28, 2017 14:14 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000047 · edgar.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,257 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 13:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 7,333 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001543407-16-000127 · edgar.xml · derivative · entry 10 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,333 Underlying: Common Stock · 7,333 shares Expires 2021-11-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 22, 2012. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 13:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 12,958 | $0.00 Strike: $76.64 | $0.00 |
DisclosureSEC source: 0001543407-16-000127 · edgar.xml · derivative · entry 9 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,958 shares Expires 2020-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 23, 2011. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 13:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 4,354 | $177.57 | $773,139.78 |
DisclosureSEC source: 0001543407-16-000127 · edgar.xml · nonDerivative · entry 6 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,188 F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $177.45 through $177.68. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 13:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 2,979 | $177.57 | $528,981.03 |
DisclosureSEC source: 0001543407-16-000127 · edgar.xml · nonDerivative · entry 5 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,542 F2 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $177.45 through $177.68. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 13:17 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 7,333 | $72.12 | $528,855.96 |
DisclosureSEC source: 0001543407-16-000127 · edgar.xml · nonDerivative · entry 4 Tharby Linda M · CIK 0001621797 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.